Similar articles

• [Properties of the receptor for cardiac glycosides (author's transl)].

  Erdmann E, Schoner W. Erdmann E, et al. Klin Wochenschr. 1974 Aug 1;52(15):705-18. doi: 10.1007/BF01469333. Klin Wochenschr. 1974. PMID: 4277912 Review. German. No abstract available.
• [Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K)-active ATPase. Clinical significance and application possibilities].

  Erdmann E, Schoner W. Erdmann E, et al. Verh Dtsch Ges Inn Med. 1974;80:1075-7. Verh Dtsch Ges Inn Med. 1974. PMID: 4281574 German. No abstract available.
• [Interaction of Na+, K+-ATPase with oubain].

  Nazarenko VI. Nazarenko VI. Ukr Biokhim Zh. 1974 Jul-Aug;46(4):531-43. Ukr Biokhim Zh. 1974. PMID: 4281547 Review. Russian. No abstract available.
• [Cardiac glycoside receptor affinity and (Na++K+)-ATPase inhibition of digitoxin, digoxin, methyldigoxin, strophanthin, proscillaridin, and meproscillarin. Measurements on isolated human cardiac cell membranes].

  Erdmann E. Erdmann E. Arzneimittelforschung. 1978;28(3a):531-5. Arzneimittelforschung. 1978. PMID: 148278 German. No abstract available.
• Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor.

  Erdmann E, Schoner W. Erdmann E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1974;283(4):335-56. doi: 10.1007/BF00501108. Naunyn Schmiedebergs Arch Pharmacol. 1974. PMID: 4278432 No abstract available.